Category Archives: AZBio News

FedEx® Deep Frozen Shipping Solution now part of BIO Business Solutions

Posted on by

BIO Business Solutions® has teamed up with FedEx to now include specialized deep frozen shipping solutions to member companies. The FedEx® Deep Frozen Shipping Solution provides innovative liquid nitrogen dry vapor technology via a cryogenic dewar along with end-to-end shipment monitoring and visibility. Specifically suited for preserving the integrity of biogenics, this solution provides up to 10 days of holding time at temperature ranges down to -150˚C. The solution offers member companies several advantages:

  • Keeps tissue samples and substances deep-frozen at -150°C
  • Provides up to 10 days without need for dry ice or power
  • Meets International Air Transport Association (IATA) requirements for both infectious substances (UN3373) and non-infectious clinical samples
  • Eliminates inventory of insulated boxes and dry ice
  • Provides advanced tracking and proactive monitoring via FedEx Priority AlertTM.
  • FedEx provides end-to-end solutions to help your temperature sensitive products maintain optimum temperature while in transit across the nation or across the ocean.

Member Benefits

Discounted Flat Fee of $435 for Domestic or $750 for international shipment

Enrollment

To enroll in the FedEx® Deep Frozen Shipping Solution, click below:

More Information

For more information on FedEx® Deep Frozen Shipping Solution, call 1-888-370-3971

FedEx® Deep Frozen Shipping Solution Case Study

Read the case study below to learn how Cenetron Diagnostics was successful using the FedEx® Deep Frozen Shipping Solution to cost effectively transport and track temperature sensitive clinical trial shipments and to learn how businesses like yours are taking advantage of powerful integration solutions with FedEx. As a reminder, FedEx Web Services allows you to integrate FedEx® shipping, tracking, rating, address validation, reporting tools, and more, directly into your website.

Read more here: Cenetron_Case_Study.pdf

Eligible Affiliates

All AZBio and BIO members are eligible to utilize the BIO Business Solutions® program with FedEx.

Opportunity Alert: ECONOMIC RESEARCH ANALYST at ACA

Posted on by

The Arizona Commerce Authority is seeking an economic research analyst to join its top-notch research team in Phoenix. The ACA’s mission is to grow and strengthen Arizona’s economy and facilitate the creation of quality jobs in the state by supporting and attracting businesses in targeted, high-value base sectors. The research team compiles and analyzes economic data to assist in business attraction, business development and business retention.Continue reading→

Ventana Medical Receives FDA 510(k) Clearance for Companion Algorithm ER (SP1)

Posted on by

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Companion Algorithm ER (SP1)1 image analysis algorithm used with the VENTANA iScan Coreo scanner running Virtuoso2 software. With this clearance, Ventana is now the only company in the industry offering a comprehensive portfolio of FDA-cleared image analysis algorithms and digital read applications for the five key immunohistochemistry (IHC) breast markers. Continue reading→

RiboMed and NuvOx Pharma to Collaborate on Brain Cancer Drug and Companion Diagnostic Test

Posted on by

 

 

RiboMed Biotechnologies, Inc. and NuvOx Pharma today jointly announced that they have entered into a collaborative agreement that will utilize RiboMed’s epigenetic biomarker test, GliomaSTRAT™, to characterize tumors from brain cancer patients and correlate response to NuvOx’s new drug, NVX-108 in the treatment of Glioblastoma multiforme (GBM).Continue reading→

Sign Up for the Alzheimer’s Prevention Registry

Posted on by

alzheimers prevention registry


Launching a research study often takes years of work, and most of the effort occurs behind the scenes. The exciting news is that several of these studies have just launched or are close to being ready to start recruiting participants through the Alzheimer’s Prevention Registry. And more studies will launch in the coming years. Here is a snapshot of a few of the studies that will be taking place in the United States and other countries around the world:

  • A trial in 1000 adults ages 65-85 who have evidence of amyloid plaque build up in their brain based on a screening PET scan, and  who are at risk for Alzheimer’s disease but are still cognitively healthy to determine whether an experimental medication may delay cognitive decline
  • A trial in nearly 6,000 adults ages 65-83 to learn about the genetic risk for developing mild cognitive impairment due to Alzheimer’s disease and whether an experimental medication might delay the symptoms
  • Two trials in a rare, hereditary form of early-onset Alzheimer’s with experimental medications to determine if treatment delays cognitive impairment
  • And many more.

Imagine having tens of thousands of volunteers awaiting an e-mail from the Registry announcing that a study is ready to begin enrollment in their communities.  Researchers could quickly screen and fill their enrollment sites in a matter of weeks or months, not years. Saving this precious time means we get to answers faster.
This is why the Alzheimer’s Prevention Registry will play a vital role in these and other prevention trials.

Take action:   While researchers work to get these and other studies ready, you can help by continuing to encourage your friends and family to sign up for the Registry.